When it comes to blockchain technology in R&D, clearly: “It’s All About The Data Sharing”! This is the main conclusion that has come out from a Pistoia Alliance assessment of blockchain applications in life sciences R&D managed by Richard Shute of Curlew Research for The Alliance.
Over 75 scientists and developers from Big Pharma, informatics software houses and biotechs contributed to the formation of a view on what areas within R&D could be ripe for blockchain-based solutions. When surveyed, a clear majority pinpointed potential opportunities for blockchain technology to support, enhance and unlock much more collaborative Data Sharing and Data Integrity, in support of the inexorable move towards more open, global, interactive working between organisations. Blockchain-enabled solutions in this area could give data providers better controlled and more secure access for others to their data, leading to improved chances for the advancement of scientific knowledge and insight. For data consumers, this would allow them access to “real” data that they would not normally be able to get at. For data consumers, this would allow them access to “real” data that they would not normally be able to get at. Solutions in this space could make the aspirational FAIR Data Principles that much more achievable.
Whilst data sharing and integrity came out as highest priority when the community was surveyed, they also identified that blockchain could potentially help with challenges around the clinical trials process and digital identity.
To read more go here: http://www.pistoiaalliance.org/its-all-about-the-data-sharing-pistoia-alliances-blockchain-in-life-sciences-rd-project-idea-assessment-completes/